common side effects of jentadueto
lactic acidosis
hypoglycemia
other side effects
vitamin b serum concentrate
comprehensive list of adverse effects
reported adverse events
nasopharyngitis
diarrhea
linagliptin-metformin
frequency
hypoglycemialinagliptin
hypertriglyceridemia
hyperlipidemia
weight increasedmetformin
lactic acidosis
vitamin b deficiency
hypoglycemia
patients
combination linagliptin
metformin
sulfonylurea
receiving metformin
sulfonylurea
n =-rrb-
gastrointestinal events
nausea
vomiting
diarrhea
appetite
abdominal pain
initiation of therapy
most cases
clinical trials
pancreatitis
cases
patient year exposure in patients
receiving linagliptin
cases
patient year exposure in those
receiving active comparator
sulfonylurea
following completion of clinical trials
additional cases of pancreatitis
receiving linagliptin
postmarketing reports of acute pancreatitis
including fatalities
linagliptin-metformin
decreased appetite
diarrhea
nausea
vomitinguncommon
increased blood amylasepostmarketing reports
mouth ulcerationlinagliptin
constipation
diarrhea frequency
pancreatitis metformin
diarrhea
nausea
vomiting
abdominal pain
appetitecommon
constipation frequency
flatulence
indigestion
linagliptin-metformin
drug hypersensitivitylinagliptinpostmarketing reports
serious hypersensitivity reactions
serious hypersensitivity reactions
anaphylaxis
angioedema
exfoliative skin conditions
been reported postmarketing in patients
linagliptin
reactions
first months
occurring after the first dose
linagliptin-metformincommon
nasopharyngitis
coughlinagliptin common
nasopharyngitis
coughmetformincommon
nasopharyngitis
postmarketing reports of bullous pemphigoid
requiring hospitalization
dipeptidyl peptidase
inhibitors
case
systemic immunosuppressive treatment
discontinuation of dpp
inhibitor
linagliptin-metformin
pruritus postmarketing reports
angioedema
urticaria
rashmetformin
skin reactions
erythema
pruritus
urticariadipeptidyl peptidase
inhibitors
postmarketing reports
bullous pemphigoid
metforminvery
megaloblastic anemia
metformin
hepatitis
liver function test abnormalities
linagliptin
frequency
myalgia
arthralgia
october
december
cases of severe arthralgia
fda
adverse event reporting system database
case
use
more dipeptidyl peptidase
inhibitor
cases
substantial reduction in prior activity level
patients
disabling
disabling joint pain
cases
symptoms
month
starting therapy
cases symptoms
month after discontinuation
positive rechallenge
cases
cases
involving use of a different dpp
inhibitor
sitagliptin
greatest number of cases
n =-rrb-
saxagliptin
n =-rrb-
linagliptin
n =-rrb-
alogliptin
n =-rrb-
vildagliptin
n =-rrb-
metformin
taste disturbance
linagliptin
urinary tract infection
linagliptin
headachemetformin
headache
anxiety
blurred vision
chills
cold sweats
coma
confusion
cool, pale skin
depression
dizziness
fast heartbeat
headache
increased hunger
nausea
nightmares
seizures
shakiness
slurred speech
unusual tiredness
weakness
bloating
constipation
darkened urine
fainting spells
fever
indigestion
irregular heartbeat
hive-like swelling on the face
eyelids
lips
tongue
throat
hands
legs
feet
sex organs
loss of appetite
pains in the stomach
side
abdomen
radiating
back
severe joint pain
vomiting
yellow eyes
skin
diarrhea
excess air
gas in the stomach
intestines
full feeling
heartburn
lack
loss of strength
muscle aches
passing gas
sore throat
runny nose
cough
decreased appetite
difficulty with moving
flaking
falling
skin
hives
welts
itching
skin rash
muscle
cramping
muscle pains
stiffness
redness of the skin
swollen joints